Clinical Trials at the NYU/Bellevue ACTU


Clinical Trials Prevention Project AIDS Clinical Trials Unit First Call NYU The NYU Long-term Nonprogressors Study Oral HPV Study for HIV-Positive Men Primary HIV Infection Study Bellevue Virology Clinic The Men's Sexual Health Project HIV Basics Dictionary Symptoms of HIV Diagnosis of HIV Understanding HIV Test Results Guide to Sexually Transmitted Infections Substance Use and HIV/AIDS HIV Prevention Clinical Trial Basics Treatment Options Women and HIV Immigration and HIV Children and HIV Demographics HIV Lifecycle and Cell-Entry Animations About Us About the AIDS Clinical Trials Unit About the Prevention Project About the NYU School of Medicine CFAR About the Bellevue Virology About the NYU Testing Project News Hablamos Español Opportunities for Giving Privacy and Participation Resources and Links Contact Us Contact Us Map and Directions Make an Appointment Hablamos Español

A5247 - A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination Antiretroviral Therapy (ART) with Conserved Immune Function

Study Status: Coming Soon.

Know the Symptoms of Recent HIV Infection

First Call NYU: Get Tested, It's Better to Know.

The NYU Long-term Nonprogressors Study: A collaboration of research programs to learn about the immune systems of HIV-positive people

A Guide to Sexually Transmitted Infections

HIV Lifecycle and Cell-Entry Animations

Support Our Research: Donate Now

Resources and Links